Table 1. Clinical characteristics of the study population.
HC | HCV | EVR | SVR | |
(n = 17) | (n = 20) | (n = 20) | (n = 20) | |
Age, year[mean±SEM] | 35.82±2.89 | 45.4±2.97 | 45.4±2.97 | 45.4±2.97 |
Sex, Female/male | 9/8 | 10/10 | 10/10 | 1010 |
ALT, IU/ml[mean±SEM] | n.a. | 85.9±18.76 | 32.35±5.41 | 23.3±2.16 |
HCV-RNA mean log10cps/ml±SEM | n.a. | 5.97±0.15 | <2.0 | <2.0 |
HCV genotype 1b/2a | n.a. | 10/7 | 10/7 | 10/7 |
Abbreviations: HC: healthy controls; HCV: treatment-naive patients with chronic hepatitis C; EVR: HCV patients with EVR after 3-month antiviral treatment; SVR: patients who achieved SVR after antiviral treatment; SEM: standard error of mean; n.a.: not applicable. Note: HCV genotype could not be identified in 3 patients in HCV, EVR and SVR group.